Tried and trusted
The latest findings on oxytocin — a.k.a. the ‘trust hormone’ — secure its position as a frontrunner among emerging treatments for autism.
Comments
The latest findings on oxytocin — a.k.a. the ‘trust hormone’ — secure its position as a frontrunner among emerging treatments for autism.
Genetic variations that tweak the brain’s release of oxytocin — a hormone involved in social bonding and establishing trust — may increase the risk of developing autism or traits of the disorder, according to three new studies published in the past few months.
Studying the relatively well-defined genetics of Williams syndrome may help unravel the poorly understood genetic and neurobiological roots of autism, researchers say.
Two research groups have achieved an elusive goal: producing mouse models that show distinct social and behavioral abnormalities reminiscent of autism.